Valuation: Chrome Holding Co.

Market Cap 96.6M 82.71M 77.17M 70.81M 133M 9.24B 136M 915M 357M 4.63B 363M 355M 15.34B P/E 2024
-0.38x
P/E 2025 -0.07x
Enterprise Value 65.86M 56.39M 52.62M 48.28M 90.72M 6.3B 92.51M 624M 243M 3.16B 247M 242M 10.46B EV / Sales 2024
0.53x
EV / Sales 2025 -0.06x
Free-Float
68.5%
Yield 2024 *
-
Yield 2025 -
1 year 2.41
Extreme 2.41
4.39
3 years 0.47
Extreme 0.4701
25
5 years 0.47
Extreme 0.4701
273.6
10 years 0.47
Extreme 0.4701
363.2
Manager TitleAgeSince
Chief Executive Officer 63 2025-03-22
Chief Tech/Sci/R&D Officer - 2024-08-31
Chief Tech/Sci/R&D Officer 48 2006-12-31
Director TitleAgeSince
Chairman 52 2005-12-31
Director/Board Member 57 2024-10-27
Director/Board Member 61 2024-10-27
Date Insider Type Main position Quantity % Market Cap.
8/20/25 Tax

Chief Executive Officer

5,232 0.0206%
6/9/25 Conversion

Founder

4,931,692 25.0063%
5/20/25 Tax

Chief Executive Officer

5,073 0.0257%
Change 5-day change 1-year change 3-year change Capi.($)
-2.78%-.--%-5.41%-84.65% 96.4M
-0.07%+4.52%+102.22%+517.57% 46.82B
+0.72%+3.17%+19.67%+55.21% 26.99B
-1.40%-5.77%-15.85%-34.64% 7.52B
+2.00%-0.34%+12.25%+159.17% 6.06B
-0.04%-1.47%+11.61%+66.28% 3.3B
+3.64%+4.30%-31.37%+1,602.06% 2.46B
-0.75%+0.85%+170.98%+21.99% 2.12B
+10.01%+0.72%+0.42%-51.24% 2.12B
-0.82%-1.04%+29.96%+19.43% 1.9B
Average +1.05%+1.14%+29.45%+227.12% 9.94B
Weighted average by Cap. +0.45%+2.56%+56.88%+307.43%

Financials

2024 2025
Net sales 220M 188M 175M 161M 303M 21.02B 308M 2.08B 811M 10.53B 825M 807M 34.87B 190M 163M 152M 139M 262M 18.17B 267M 1.8B 702M 9.11B 713M 698M 30.15B
Net income -667M -571M -533M -489M -918M -63.79B -936M -6.32B -2.46B -31.97B -2.5B -2.45B -106B -281M -240M -224M -206M -387M -26.88B -395M -2.66B -1.04B -13.47B -1.05B -1.03B -44.59B
Net Debt -140M -120M -112M -103M -193M -13.39B -197M -1.33B -517M -6.71B -526M -514M -22.22B -30.74M -26.32M -24.55M -22.53M -42.33M -2.94B -43.17M -291M -114M -1.47B -115M -113M -4.88B
Logo Chrome Holding Co.
Chrome Holding Co., formerly 23andMe Holding Co., is a genetics-led consumer healthcare company. As a part of TTAM Research Institute (TTAM), the Company operates and provides customers with personalized deoxyribonucleic acid (DNA) testing and research services.
Employees
261
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BBB